PMC:7594251 / 2475-2646 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14710","span":{"begin":53,"end":54},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T5958","span":{"begin":74,"end":81},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T70818","span":{"begin":127,"end":128},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"This high investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significant number of cases."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17","span":{"begin":33,"end":37},"obj":"Chemical"}],"attributes":[{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"This high investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significant number of cases."}

{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":5,"end":9},"obj":"Gene"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Gene:104137"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This high investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significant number of cases."}

{"project":"LitCovid-sentences","denotations":[{"id":"T23","span":{"begin":0,"end":171},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This high investment barrier for drug development is a result of numerous testing phases (Scheme 1), with each phase requiring a statistically significant number of cases."}